Cathelicidin Suppresses Colon Cancer Metastasis via a P2RX7-Dependent Mechanism
Open Access
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 12, 195-203
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (K01-DK084256)
- Crohn's and Colitis Foundation of America (287244)
This publication has 37 references indexed in Scilit:
- FK-16 Derived from the Anticancer Peptide LL-37 Induces Caspase-Independent Apoptosis and Autophagic Cell Death in Colon Cancer CellsPLOS ONE, 2013
- MiR-200c and HuR in ovarian cancerBMC Cancer, 2013
- The antimicrobial peptide cathelicidin modulates Clostridium difficile -associated colitis and toxin A-mediated enteritis in miceGut, 2012
- Investigating dynamical deformations of tumor cells in circulation: predictions from a theoretical modelFrontiers in Oncology, 2012
- Cathelicidin Signaling via the Toll-like Receptor Protects Against Colitis in MiceGastroenterology, 2011
- Substance P Modulates Colitis-Asscociated FibrosisThe American Journal of Pathology, 2010
- Emerging roles of the host defense peptide LL‐37 in human cancer and its potential therapeutic applicationsInternational Journal of Cancer, 2010
- Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juiceBMC Microbiology, 2009
- Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour responseBritish Journal of Cancer, 2009
- Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13Journal of Antimicrobial Chemotherapy, 2008